Terms: = Liver cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
411 results:
1. Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapies.
Wang ZY; Xu B; Wang LN; Zhu XD; Huang C; Shen YH; Li H; Li ML; Zhou J; Fan J; Sun HC
Int Immunopharmacol; 2024 Apr; 131():111863. PubMed ID: 38492340
[TBL] [Abstract] [Full Text] [Related]
2. [cancer incidence and mortality in China, 2022].
Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
[No Abstract] [Full Text] [Related]
3. Tampa Difficulty Score: a novel scoring system for difficulty of robotic hepatectomy.
Sucandy I; Dugan MM; Ross SB; Syblis C; Crespo K; Kenary PY; Rosemurgy A
J Gastrointest Surg; 2024 May; 28(5):685-693. PubMed ID: 38462424
[TBL] [Abstract] [Full Text] [Related]
4. Genetic variants in m5C modification genes are associated with survival of patients with HBV-related hepatocellular carcinoma.
Chen B; Qiu M; Gong R; Liu Y; Zhou Z; Wen Q; Wei X; Liang X; Jiang Y; Chen P; Wei Y; Huang Q; Mo Q; Lin Q; Yu H
Arch Toxicol; 2024 Apr; 98(4):1125-1134. PubMed ID: 38438738
[TBL] [Abstract] [Full Text] [Related]
5. All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines.
Tian LY; Smit DJ; Popova NV; Horn S; Velasquez LN; Huber S; Jücker M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396845
[TBL] [Abstract] [Full Text] [Related]
6. Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma.
Gil-Rojas S; Suárez M; Martínez-Blanco P; Torres AM; Martínez-García N; Blasco P; Torralba M; Mateo J
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396674
[TBL] [Abstract] [Full Text] [Related]
7. Role of intravoxel incoherent motion (IVIM) imaging in response assessment of hepatocellular carcinoma after transarterial chemoembolization (TACE) - A prospective study.
Reddy Bursapalle M; Valakkadaa J; Ayappan A
Radiologia (Engl Ed); 2024; 66(1):23-31. PubMed ID: 38365352
[TBL] [Abstract] [Full Text] [Related]
8. Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
Pire A; Hirsch TZ; Morcrette G; Imbeaud S; Gupta B; Pilet J; Cornet M; Fabre M; Guettier C; Branchereau S; Brugières L; Guerin F; Laithier V; Coze C; Nagae G; Hiyama E; Laurent-Puig P; Rebouissou S; Sarnacki S; Chardot C; Capito C; Faure-Conter C; Aerts I; Taque S; Fresneau B; Zucman-Rossi J
Eur J Cancer; 2024 Mar; 200():113583. PubMed ID: 38330765
[TBL] [Abstract] [Full Text] [Related]
9. Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month.
Chiu SH; Lin HH; Feng AC; Lo CH; Hsieh CB; Chen PK; Chang WC
Eur J Radiol; 2024 Jan; 170():111266. PubMed ID: 38185027
[TBL] [Abstract] [Full Text] [Related]
10. Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.
Luan CH; Su PS; Chu CJ; Lin CC; Su CW; Luo JC; Lee IC; Chi CT; Lee SD; Wang YJ; Lee FY; Huang YH; Hou MC
J Chin Med Assoc; 2024 Apr; 87(4):357-368. PubMed ID: 38180018
[TBL] [Abstract] [Full Text] [Related]
11. The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline.
Meng Z; Li P; Yang D; Huang H; Dong H; Qin Y; Bin Y; Li R; Wang S; Chen X; Kang M
Radiother Oncol; 2024 Feb; 191():110027. PubMed ID: 38008418
[TBL] [Abstract] [Full Text] [Related]
12. Quantitative diffusion weighted imaging in patients with hepatocellular carcinoma: effects of simultaneous multi-slice acceleration and gadoxetic acid administration.
Yang T; Ye Z; Yao S; Wu Y; Yin T; Song B
Abdom Radiol (NY); 2024 Mar; 49(3):683-693. PubMed ID: 37930449
[TBL] [Abstract] [Full Text] [Related]
13. Dose Volume and liver Function Test Relationship following Radiotheraphy for Right Breast cancer: A Multicenter Study.
Güzelöz Z; Ayrancıoğlu O; Aktürk N; Güneş M; Alıcıkuş ZA
Curr Oncol; 2023 Sep; 30(10):8763-8773. PubMed ID: 37887532
[TBL] [Abstract] [Full Text] [Related]
14. Value of GPR, APPRI and FIB-4 in the early diagnosis of hepatocellular carcinoma: a prospective cohort study.
Zhang L; Li S; Zhang D; Yin C; Wang Z; Chen R; Cheng N; Bai Y
Jpn J Clin Oncol; 2024 Feb; 54(2):129-136. PubMed ID: 37869774
[TBL] [Abstract] [Full Text] [Related]
15. Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma.
Zhao YM; Xie SS; Wang J; Zhang YM; Li WC; Ye ZX; Shen W
BMC Med Imaging; 2023 Sep; 23(1):138. PubMed ID: 37737166
[TBL] [Abstract] [Full Text] [Related]
16. Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal liver Metastasis: A Retrospective Cohort Study.
Chen Y; Zhu D; Chen M; Xu Y; Ye Q; Wang X; Xu P; Feng Q; Ji M; Wei Y; Fan J; Xu J
Clin Colorectal Cancer; 2023 Dec; 22(4):464-473.e5. PubMed ID: 37730473
[TBL] [Abstract] [Full Text] [Related]
17. Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL).
Cash E; Deitz K; Potts KL; Nabeta HW; Zahin M; Rai SN; Dryden GW; Palmer KE
BMJ Open; 2023 Sep; 13(9):e073735. PubMed ID: 37699630
[TBL] [Abstract] [Full Text] [Related]
18. Ultra-Processed Food Consumption and Mortality: Three Cohort Studies in the United States and United Kingdom.
Zhao Y; Chen W; Li J; Yi J; Song X; Ni Y; Zhu S; Zhang Z; Xia L; Zhang J; Yang S; Ni J; Lu H; Wang Z; Nie S; Liu L
Am J Prev Med; 2024 Feb; 66(2):315-323. PubMed ID: 37690589
[TBL] [Abstract] [Full Text] [Related]
19. Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study.
Gu HX; Huang XS; Xu JX; Zhu P; Xu JF; Fan SF
J Digit Imaging; 2023 Dec; 36(6):2554-2566. PubMed ID: 37578576
[TBL] [Abstract] [Full Text] [Related]
20. Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study.
Yu W; Liu W; Zhang K; Chen S; Wang X
Cancer Immunol Immunother; 2023 Nov; 72(11):3609-3619. PubMed ID: 37566127
[TBL] [Abstract] [Full Text] [Related]
[Next]
